Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Biologics and Biosimilars market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Biologics and Biosimilars are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Biologics and Biosimilars market segmented into
Packing Industry
PHA
Bio-PE
Starch Blends
PLA
Others
Based on the end-use, the global Biologics and Biosimilars market classified into
Packing Industry
Automotive Industry
Bottles manufacturing
Others
Based on geography, the global Biologics and Biosimilars market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
NatureWorks
Braskem
BASF
Arkema
DuPont
Novamont
Corbion
Metabolix
PSM
PolyOne
Biome Bioplastics
Biomer
FKuR
Trellis Bioplastics
Kingfa
Cardia Bioplastics
Grabio
MHG
Myriant
Mitsubishi
Zhejiang Hisun Biomaterials
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICS AND BIOSIMILARS INDUSTRY
2.1 Summary about Biologics and Biosimilars Industry
2.2 Biologics and Biosimilars Market Trends
2.2.1 Biologics and Biosimilars Production & Consumption Trends
2.2.2 Biologics and Biosimilars Demand Structure Trends
2.3 Biologics and Biosimilars Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Bio-PET
4.2.2 PHA
4.2.3 Bio-PE
4.2.4 Starch Blends
4.2.5 PLA
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Packing Industry
4.3.2 Automotive Industry
4.3.3 Bottles manufacturing
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Bio-PET
5.2.2 PHA
5.2.3 Bio-PE
5.2.4 Starch Blends
5.2.5 PLA
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Packing Industry
5.3.2 Automotive Industry
5.3.3 Bottles manufacturing
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Bio-PET
6.2.2 PHA
6.2.3 Bio-PE
6.2.4 Starch Blends
6.2.5 PLA
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Packing Industry
6.3.2 Automotive Industry
6.3.3 Bottles manufacturing
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Bio-PET
7.2.2 PHA
7.2.3 Bio-PE
7.2.4 Starch Blends
7.2.5 PLA
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Packing Industry
7.3.2 Automotive Industry
7.3.3 Bottles manufacturing
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Bio-PET
8.2.2 PHA
8.2.3 Bio-PE
8.2.4 Starch Blends
8.2.5 PLA
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Packing Industry
8.3.2 Automotive Industry
8.3.3 Bottles manufacturing
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Bio-PET
9.2.2 PHA
9.2.3 Bio-PE
9.2.4 Starch Blends
9.2.5 PLA
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Packing Industry
9.3.2 Automotive Industry
9.3.3 Bottles manufacturing
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 NatureWorks
10.1.2 Braskem
10.1.3 BASF
10.1.4 Arkema
10.1.5 DuPont
10.1.6 Novamont
10.1.7 Corbion
10.1.8 Metabolix
10.1.9 PSM
10.1.10 PolyOne
10.1.11 Biome Bioplastics
10.1.12 Biomer
10.1.13 FKuR
10.1.14 Trellis Bioplastics
10.1.15 Kingfa
10.1.16 Cardia Bioplastics
10.1.17 Grabio
10.1.18 MHG
10.1.19 Myriant
10.1.20 Mitsubishi
10.1.21 Zhejiang Hisun Biomaterials
10.2 Biologics and Biosimilars Sales Date of Major Players (2017-2020e)
10.2.1 NatureWorks
10.2.2 Braskem
10.2.3 BASF
10.2.4 Arkema
10.2.5 DuPont
10.2.6 Novamont
10.2.7 Corbion
10.2.8 Metabolix
10.2.9 PSM
10.2.10 PolyOne
10.2.11 Biome Bioplastics
10.2.12 Biomer
10.2.13 FKuR
10.2.14 Trellis Bioplastics
10.2.15 Kingfa
10.2.16 Cardia Bioplastics
10.2.17 Grabio
10.2.18 MHG
10.2.19 Myriant
10.2.20 Mitsubishi
10.2.21 Zhejiang Hisun Biomaterials
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Biologics and Biosimilars Product Type Overview
2.Table Biologics and Biosimilars Product Type Market Share List
3.Table Biologics and Biosimilars Product Type of Major Players
4.Table Brief Introduction of NatureWorks
5.Table Brief Introduction of Braskem
6.Table Brief Introduction of BASF
7.Table Brief Introduction of Arkema
8.Table Brief Introduction of DuPont
9.Table Brief Introduction of Novamont
10.Table Brief Introduction of Corbion
11.Table Brief Introduction of Metabolix
12.Table Brief Introduction of PSM
13.Table Brief Introduction of PolyOne
14.Table Brief Introduction of Biome Bioplastics
15.Table Brief Introduction of Biomer
16.Table Brief Introduction of FKuR
17.Table Brief Introduction of Trellis Bioplastics
18.Table Brief Introduction of Kingfa
19.Table Brief Introduction of Cardia Bioplastics
20.Table Brief Introduction of Grabio
21.Table Brief Introduction of MHG
22.Table Brief Introduction of Myriant
23.Table Brief Introduction of Mitsubishi
24.Table Brief Introduction of Zhejiang Hisun Biomaterials
25.Table Products & Services of NatureWorks
26.Table Products & Services of Braskem
27.Table Products & Services of BASF
28.Table Products & Services of Arkema
29.Table Products & Services of DuPont
30.Table Products & Services of Novamont
31.Table Products & Services of Corbion
32.Table Products & Services of Metabolix
33.Table Products & Services of PSM
34.Table Products & Services of PolyOne
35.Table Products & Services of Biome Bioplastics
36.Table Products & Services of Biomer
37.Table Products & Services of FKuR
38.Table Products & Services of Trellis Bioplastics
39.Table Products & Services of Kingfa
40.Table Products & Services of Cardia Bioplastics
41.Table Products & Services of Grabio
42.Table Products & Services of MHG
43.Table Products & Services of Myriant
44.Table Products & Services of Mitsubishi
45.Table Products & Services of Zhejiang Hisun Biomaterials
46.Table Market Distribution of Major Players
47.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
48.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
49.Table Global Biologics and Biosimilars Market Forecast (Million USD) by Region 2021f-2026f
50.Table Global Biologics and Biosimilars Market Forecast (Million USD) Share by Region 2021f-2026f
51.Table Global Biologics and Biosimilars Market Forecast (Million USD) by Demand 2021f-2026f
52.Table Global Biologics and Biosimilars Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Biologics and Biosimilars Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Biologics and Biosimilars Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Biologics and Biosimilars Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Biologics and Biosimilars Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Biologics and Biosimilars Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Biologics and Biosimilars Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Biologics and Biosimilars Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Bio-PET Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure PHA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Bio-PE Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Starch Blends Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure PLA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Packing Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Automotive Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Bottles manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Bio-PET Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure PHA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Bio-PE Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Starch Blends Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure PLA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Packing Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Automotive Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Bottles manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Bio-PET Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure PHA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Bio-PE Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Starch Blends Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure PLA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Packing Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Automotive Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Bottles manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Bio-PET Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure PHA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Bio-PE Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Starch Blends Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure PLA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Packing Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Automotive Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Bottles manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Bio-PET Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure PHA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Bio-PE Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Starch Blends Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure PLA Segmentation Market Size (USD
The Biologics Outsourcing Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Sterile Biologics Filling Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...